.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,717,097

« Back to Dashboard

Details for Patent: 5,717,097

Title: HIV protease inhibitors useful for the treatment of AIDS
Abstract:Compounds of formula ##STR1## where A is usually carbonyl or --CH.sub.2 --, D is usually --CH.sub.2 --; R.sup.1 and R.sup.2 are independently hydrogen or optionally-substituted C.sub.1-4 alkyl or aryl, or R.sup.1 and R.sup.2 are joined together to form a monocyclic or bicyclic ring system, are HIV protease inhibitors. These compounds are useful in the prevention or treatment of infection by HIV and in the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
Inventor(s): Vacca; Joseph P. (Telford, PA), Dorsey; Bruce D. (Harleysville, PA), Guare; James P. (Quakertown, PA), Holloway; M. Katharine (Lansdale, PA), Hungate; Randall W. (Lansdale, PA), Levin; Rhonda B. (Lafayette Hill, PA), Huff; Joel R. (Gwynedd Valley, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Filing Date:Dec 04, 1996
Application Number:08/759,203
Claims:1. A process for making a compound of the formula I ##STR273## comprising reacting a compound (i) of the formula ##STR274## with R.sup.1 --X; wherein R.sup.1 is C.sub.1-4 alkyl unsubstituted or substituted with one or more of

(1) aryl unsubstituted or substituted with one or more of C.sub.1-4 alkyl, amino, hydroxy or aryl;

(2) a 5-7 membered cycloalkyl group unsubstituted or substituted with one or more of halo, C1-3 alkoxy or aryl; or

(3) heterocycle unsubstituted or substituted with one or more of oxo, halo, C.sub.1-4 alkoxy, C.sub.1-4 alkyl, --C(O)OC.sub.1-3 alkyl, --NHC(O)C.sub.1-3 alkyl, or Boc; and

X is selected from Cl, Br or I;

to give the compound of formula I.

2. The process of claim 1, wherein

R.sup.1 is C.sub.1-4 alkyl unsubstituted or substituted with a heterocycle wherein the heterocycle is unsubstituted or substituted with one or more of oxo, halo, C.sub.1-4 alkoxy, C.sub.1-4 alkyl, --C(O)OC.sub.1-3 alkyl, --NHC(O)C.sub.1-3 alkyl, or Boc.

3. The process of claim 2, wherein

R.sup.1 is C.sub.1-4 alkyl substituted with a heterocycle, wherein the heterocycle is selected from piperidinyl, pyridyl, thienyl, pyrrolyl, thiazolyl, imidazolyl, furyl, benzimidazolyl, pyrazinyl, isoxazolyl, pyridazinyl, or quinolinyl, and wherein the heterocycle is unsubstituted or substituted with one or more of oxo, halo, C.sub.1-4 alkoxy, C.sub.1-4 alkyl, --C(O)OC.sub.1-3 alkyl, --NHC(O)C.sub.1-3 alkyl, or Boc.

4. The process of claim 3 for making a compound J of the formula ##STR275## comprising reacting a compound (i) of the formula ##STR276## with a compound of the formula ##STR277## to give the compound J.

5. The process of claim 4 for making a compound J of the formula ##STR278## comprising reacting a compound (i) of the formula ##STR279## with 3-picolyl chloride to give the compound J.

6. A compound (i) of the formula: ##STR280## or a salt thereof.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc